Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs ; volume:18 ; number:1 ; day:14 ; month:1 ; year:2019 ; pages:1-12 ; date:12.2019
Malaria journal ; 18, Heft 1 (14.1.2019), 1-12, 12.2019
- Creator
-
Tougan, Takahiro
Toya, Yuji
Uchihashi, Kinya
Horii, Toshihiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12936-019-2642-0
- URN
-
urn:nbn:de:101:1-2019021923331793946999
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tougan, Takahiro
- Toya, Yuji
- Uchihashi, Kinya
- Horii, Toshihiro
- SpringerLink (Online service)
Other Objects (12)
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies
Synergistic anti-malarial action of cryptolepine and artemisinins
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies
Synergistic anti-malarial action of cryptolepine and artemisinins
Correlation between anti-malarial and anti-haemozoin activities of anti-malarial compounds
An in vitro toolbox to accelerate anti-malarial drug discovery and development
Drug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate
Anti-malarial effect of gum arabic
Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
Anti-Malarial work in the Huleh Valley
Novel pantothenate derivatives for anti-malarial chemotherapy
Substandard anti-malarial drugs in Burkina Faso
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
Towards optimal design of anti-malarial pharmacokinetic studies